Texas woman livestreams breast cancer surgery to 26,000 Facebook users
Sonia Johnson of Texas was diagnosed with breast cancer last December. In honor of breast cancer awareness month and in the hopes others will get checked, she streamed her lumpectomy today. (Source: the Mail online | Health)
Source: the Mail online | Health - October 25, 2018 Category: Consumer Health News Source Type: news
Researchers Want Cancer Patients To Share Their Medical Information In Search of Cures
April Doyle, a single mom from Visalia, Cal., only lets herself look three months into her future. Since she was first diagnosed with breast cancer in 2014, she’s tried a new treatment every three months to keep the cancer from spreading from her breast tissue to other parts of her body. But it returned: this time in her bone. She is almost out of options for her hard-to-treat cancer, but she finds comfort in online support groups where other women with metastatic breast cancer share their experiences. “Eventually we know we will exhaust all of our options until they keep coming up with more treatments,” ...
Source: TIME: Health - October 18, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer healthytime Source Type: news
Mastectomy Not the Only Option in Extensive DCIS
(MedPage Today) -- Lumpectomy plus RT viable if risks, benefits are explained (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - September 28, 2018 Category: OBGYN Source Type: news
Lumpectomy + Radiation May Cut Breast Cancer Mortality in DCIS
Lumpectomy, radiotherapy tied to reduction in breast cancer mortality versus lumpectomy, mastectomy (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 20, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Radiology, Surgery, Journal, Source Type: news
Lumpectomy & #43; Radiation May Cut Breast Cancer Mortality in DCIS
MONDAY, Aug. 20, 2018 -- Treatment with lumpectomy and radiotherapy is associated with a reduction in breast cancer mortality versus lumpectomy or mastectomy alone among patients with ductal carcinoma in situ (DCIS), according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 20, 2018 Category: Pharmaceuticals Source Type: news
Is radiation therapy warranted for DCIS postlumpectomy?
Researchers have found that radiation therapy after lumpectomy in women with...Read more on AuntMinnie.comRelated Reading: Microbubbles improve breast cancer radiation therapy ASTRO: Short radiation course safe for breast cancer LED device could predict skin damage from breast RT Robotic IMRT-APBI works well for breast cancer patients SABCS: Study links APBI to higher complication rates (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 10, 2018 Category: Radiology Source Type: news
Lumpectomy Plus RT Tied to Lower Mortality in DCIS Lumpectomy Plus RT Tied to Lower Mortality in DCIS
Lumpectomy plus radiation is associated with a small but statistically significant reduced risk for breast cancer-related death compared to the other major options for ductal carcinoma in situ (DCIS).Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 10, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Association of radiation therapy plus lumpectomy in reduced risk of dying in women with DCIS
(JAMA Network) Lumpectomy plus radiation was associated with a small clinical benefit in reduced risk of breast cancer death compared with lumpectomy or mastectomy alone in women with ductal carcinoma in situ (DCIS), a noninvasive early form of breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 10, 2018 Category: Cancer & Oncology Source Type: news
Dune Medical debuts waste-saving surgical probe
Dune Medical Devices has designed a reposable version of its MarginProbe radiofrequency spectropscopy device, which can help surgeons identify remaining cancer cells in real time during a lumpectomy. The updated MarginProbe has a reusable cable and handle and a single-use attachable probe. It has the potential to reduce waste burden of the MarginProbe up to 50%, according to the company. The technology uses radio-frequency (RF) electrical fields to probe the surface of the cancerous lump removed from the breast, enabling the surgeon to remove additional tissue from the breast during the same procedure and avoid ...
Source: Mass Device - July 11, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Radiosurgery Surgical Dune Medical Devices Inc. Source Type: news
More Women With Breast Cancer May Soon Be Skipping Chemo. Here ’s Why
Phyllis Lacetti found her own breast cancer when she felt an abnormal lump in her right breast in 2007. A nurse at Montefiore Medical Center, she had a lumpectomy to remove it, but an MRI afterward revealed remaining cancer cells, so she opted to get a mastectomy. Her cancer doctor recommended she get chemotherapy to ensure that her cancer wouldn’t recur, since Lacetti’s family history put her at high risk. Her sister and father had died of leukemia, and her brother passed away from thyroid cancer. Chemotherapy, he said, was her best option for preventing the cancer from returning. But Lacetti was reticent abo...
Source: TIME: Health - June 7, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer healthytime Source Type: news
Campaigning for Evidence: Sara Yaron - a patient's story
Sara Yaronhas been an active consumer ’s advocate since 1982, when she was first diagnosed with breast cancer. By profession, she’s a private lawyer in Israel, engaged in medical malpractice lawsuits. After her diagnosis, she became involved with national and international organizations, all regarding health care, patient safety, pa tients rights to get updated medical information based on evidence, and patients rights.She recently was re-appointed to the Cochrane Consumer Network (CCNet) Executive for a further period of three years to 2021. Below is her story on how she got involved as a consumer advocate wit...
Source: Cochrane News and Events - June 6, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news
Less Recurrence After Lumpectomy than Previously Thought (CME/CE)
(MedPage Today) -- New data may help inform choice between lumpectomy and mastectomy (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - May 4, 2018 Category: Primary Care Source Type: news
Meta-analysis: Recurrence Rates After Lumpectomy Have Improved Meta-analysis: Recurrence Rates After Lumpectomy Have Improved
More than ever before, breast-conserving surgery is a treatment option for more breast cancer patients, say experts.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 4, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
What's the best way to follow up breast cancer survivors?
How should women with breast cancer be tracked after lumpectomy or mastectomy?...Read more on AuntMinnie.comRelated Reading: Women don't know about breast cancer treatment options At-risk women not receiving breast MRI scans Most women prefer annual breast cancer screening Screening breast MRI alone OK for high-risk women Mammography guidelines don't change screening intervals (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 18, 2018 Category: Radiology Source Type: news
How a Tiny Breast Cancer Device Carries Big Value
With all the uncertainty in today's healthcare system, the one thing everyone seems to agree on is that value-based care is here to stay. Cianna Medical understands that particularly well, and the company's latest FDA clearance is expected to add even more value to the continuum of care for breast cancer patients and their providers. Cianna's Savi Scout reflector can now be implanted in breast cancer patients without restrictions on the length of time that it can remain in the breast. The device is a non-radioactive implant used in wire-free localization. It is only activated when a special handpiece, which acts as the rad...
Source: MDDI - November 16, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: Implants Source Type: news
FDA clears Cianna Medical ’ s Savi Scout breast cancer locator for long term implants
Cianna Medical said today that the Savi Scout reflector, part of its system for wire-free breast tumor localization, won FDA clearance as the first non-radioactive implant without a restriction on the length of time that the reflector can remain in a patient’s breast. The new clearance means that doctors can place Scout to mark a biopsy or lumpectomy site and not be constrained by a maximum implant time, the Aliso Viejo, Calif.-based company said. The Scout reflector also won’t interfere with MRI studies, so doctors aren’t restricted in the types of imaging modalities they can use with their patients. The...
Source: Mass Device - November 13, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Food & Drug Administration (FDA) Oncology Regulatory/Compliance Women's Health Cianna Medical Source Type: news
Older Patients With Breast Cancer Still Overtreated With RT -- Why? Older Patients With Breast Cancer Still Overtreated With RT -- Why?
Surgeons and radiation oncologists frequently overestimate the benefits of radiotherapy (RT) after lumpectomy and thus continue to recommend its use, despite a lack of evidence for a survival benefit or protection against local recurrence.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 11, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Why More Women Are Getting a Double Mastectomy
Recent research has shown that despite more having more treatment options, women with cancer in one breast are increasingly choosing to remove both breasts—even though experts in the field say the procedure is not necessarily accompanied by better outcomes. Now, a new study published Wednesday in JAMA Surgery finds that the increase is being driven in part by their surgeons. Doctors generally discourage contralateral prophylactic mastectomy—also known as CPM, or the removal of a healthy breast when the other has cancer—for women at an average risk for additional breast cancer. They do recommend it for wo...
Source: TIME.com: Top Science and Health Stories - September 13, 2017 Category: Consumer Health News Authors: Alexandra Sifferlin Tags: Uncategorized Breast Cancer breast cancer treatment contralateral prophylactic mastectomy double mastectomy lumpectomy symptoms breast cancer Source Type: news
Local DCIS Recurrence After Skipping Adjuvant Radiation Local DCIS Recurrence After Skipping Adjuvant Radiation
Omitting radiation after lumpectomy for pure ductal carcinoma in situ (DCIS) does not improve the chance of breast preservation in case of local recurrence, researchers from Canada have observed.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 6, 2017 Category: Surgery Tags: Hematology-Oncology News Source Type: news
iCad wins Chinese approval for Xoft Axxent balloon applicators
iCad (NSDQ:ICAD) said today its Xoft Axxent balloon applicators have been cleared by the China Food & Drug Administration for treating early-stage breast cancer. The Nashua, N.H.-based company’s Xoft Axxent balloon applicators are part of its Xoft Axxent electronic brachytherapy system designed to perform intraoperative radiation therapy in early-stage breast cancer patients who meet specific selection criteria. The balloon applicator is used to deliver a single dose of radiation to the lumpectomy cavity to target cancer cells directly and limit exposure to health surrounding tissue, iCad said. “The Xo...
Source: Mass Device - August 30, 2017 Category: Medical Devices Authors: Fink Densford Tags: Oncology Regulatory/Compliance Women's Health iCad Inc. Source Type: news
Dune Medical relocates US HQ to Atlanta
Dune Medical Devices said today it is relocating its US headquarters to Alpharetta, Ga., near Atlanta, from Paoli, Penn. as the company looks to expand its portfolio and improve uptake and reimbursement for its MarginProbe device. The MarginProbe is a breast cancer surgical device designed for real-time detection of cancer in breast conserving surgeries, the company said. The system uses the company’s proprietary radiofrequency spectroscopy technology to help surgeons identify microscopic residual cancer at surgical margins during surgery. “Dune’s proprietary technology is already demonstrating high value...
Source: Mass Device - August 14, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Dune Medical Devices Inc. Source Type: news
Research evaluates impact of surgical modality on breast-specific sensuality
(Care New England) Does the type of surgery used to treat breast cancer impact a woman's sensuality and sexual function in survivorship? New research from Women& Infants Hospital analyzed the association of surgical modality with sexual function and found that breast-specific sensuality and appearance satisfaction are better with lumpectomy and may correlate with improved sexual function post-operatively. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 26, 2017 Category: International Medicine & Public Health Source Type: news
Medical device company raises $12.3 million, plans move to Atlanta
Dune's MarginProbe System is used during breast cancer lumpectomy procedures to test whether the surgery has removed all the cancerous cells. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 11, 2017 Category: Biotechnology Authors: Ellie Hensley Source Type: news
Dune Medical raises $12m to expand MarginProbe footprint
Dune Medical Devices said today that it raised another $12 million it plans to use to expand the indications for the radiofrequency spectroscopy technology used in its MarginProbe cancer detection device. Alpharetta, Ga.- and Caesarea, Israel-based Dune said the $12.3 million round was led by Canepa Healthcare, ATON Partners and the Kraft Group. Dune said it plans to use the funds to find other cancers the technology, which is designed to provide real-time detection of cancer cells on the margins of tumors. MarginProbe won FDA approval for use in breast lumpectomies in January 2013; today the company said more th...
Source: Mass Device - July 6, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Imaging Oncology Wall Street Beat Women's Health Dune Medical Devices Inc. Source Type: news
Microscope can scan tumors during surgery and examine cancer biopsies in 3-D
(University of Washington) A new UW microscope could provide accurate real-time results during cancer-removal surgeries, potentially eliminating the 20 to 40 percent of women who have to undergo multiple lumpectomy surgeries because cancerous breast tissue is missed the first time around. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 26, 2017 Category: Cancer & Oncology Source Type: news
Complications of Local Therapies for Early Breast Cancer Complications of Local Therapies for Early Breast Cancer
Does mastectomy plus reconstruction result in more complications and higher cost than lumpectomy plus whole breast irradiation?Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 15, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
ASCO: Recent Drop in Additional Surgery Post Lumpectomy
Decrease was concomitant with 2014 consensus statement endorsing a margin of no ink on tumor (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 6, 2017 Category: Cancer & Oncology Tags: Gynecology, Oncology, Surgery, Conference News, Source Type: news
Trends in reoperation after initial lumpectomy for breast cancer
(The JAMA Network Journals) Monica Morrow, M.D., of Memorial Sloan Kettering Cancer Center, New York, and coauthors investigated the impact of a 2014 consensus statement endorsing a minimal negative margin for invasive breast cancer on postlumpectomy surgery and final surgical treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 5, 2017 Category: Cancer & Oncology Source Type: news
Photoacoustic imaging could guide breast cancer removal
A new technique based on photoacoustic imaging could help surgeons determine...Read more on AuntMinnie.comRelated Reading: Contrast US helps assess breast cancer treatment response Bilateral mastectomy not needed for DCIS DBT reduces breast surgery re-excision rates Supine MRI in the OR can improve breast surgery outcome Lumpectomy with RT tops mastectomy for early-stage cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 17, 2017 Category: Radiology Source Type: news
Decision Making in the Surgical Management of Invasive Breast Cancer —Part 1: Lumpectomy, Mastectomy, and Contralateral Prophylactic Mastectomy
Breast-conserving surgery and mastectomy are equivalent treatments for invasive breast cancer patients in terms of overall survival. For the majority of patients, successful breast conservation requires a margin-negative lumpectomy and access to WBRT. CPM yields no definitive survival advantage. (Source: CancerNetwork)
Source: CancerNetwork - May 15, 2017 Category: Cancer & Oncology Authors: Lisa A. Newman, MD, MPH Tags: Breast Cancer Oncology Journal Review Article Source Type: news
Breast Reconstruction of a Nipple Areolar Lumpectomy Defect Breast Reconstruction of a Nipple Areolar Lumpectomy Defect
The authors describe a novel technique for the oncoplastic reconstruction of a nipple-areola complex lumpectomy defect.ePlasty, Open Access Journal of Plastic Surgery (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - May 8, 2017 Category: Surgery Tags: Plastic Surgery & Aesthetic Medicine Journal Article Source Type: news
7 medtech stories we missed this week: May 5, 2017
[Image from unsplash.com]From Biomerics’s $38.5 million expansion in Salt Lake City to new study results and partnerships, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. Biomerics opening new corporate HQ Biomerics announced in a May 1 press release that it is moving its corporate headquarters in Salt Lake City. The new facility will be 230,000 sq. ft and will be located in the International Center. It will have corporate offices, engineering offices, research and development labs and cleanroom manufacturing. Biomerics is expected to invest $38.5 million in the expansi...
Source: Mass Device - May 5, 2017 Category: Medical Equipment Authors: Danielle Kirsh Tags: Clinical Trials Food & Drug Administration (FDA) Imaging Pre-Market Approval (PMA) Regulatory/Compliance Research & Development Accuray Inc. Biomerics Glytec medPhoton MedTech Mevion Medical Systems Neural Analytics RAPS Refocu Source Type: news
7 medtech stories we missed this week: April 7, 2017
[Image from unsplash.com]New studies for umbilical cord allografts and tumor targeting were published this week while another company received European CE Marking. Here are some medtech stories we missed this week but thought were still worth mentioning. 1. AMNIOX touts new umbilical cord study AMNIOX Medical announced that it has published the results of 3 studies that demonstrate the effectiveness of umbilical cord tissue for treating chronic wounds, according to an April 7 press release. The company’s cryopreserved human umbilical cord tissue, NEOX Cord 1K was tested on 29 patients who needed a wound all...
Source: Mass Device - April 7, 2017 Category: Medical Equipment Authors: Danielle Kirsh Tags: Clinical Trials Radiosurgery Regulatory/Compliance Research & Development Spinal Wound Care Aesculap Implant Systems Amniox AngioDynamics Cianna Medical InVivo Therapeutics MedTech Nu-Med Occlutech Source Type: news
Mum using healthy eating to treat cancer
Sarah Valentine, 36, from Kent was offered either a full mastectomy or a lumpectomy and radiotherapy on the NHS, but she has defied medical advice by declining both options. (Source: the Mail online | Health)
Source: the Mail online | Health - January 23, 2017 Category: Consumer Health News Source Type: news
Potentially avoidable breast cancer surgeries cost patients and health-care system
(University of British Columbia Okanagan campus) A recent study by UBC medical researchers examined the health care costs associated with lumpectomy patients requiring reoperations. A lumpectomy, known as breast conservation surgery, is a procedure that removes tumors, aims to conserve breast tissue, and is followed by radiation therapy.The study concluded that with Canadian reoperation rates being more than double recommended targets, the additional cost to BC's health care system alone is $2 million per year. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 15, 2016 Category: Cancer & Oncology Source Type: news
Upstate Breast Care Center at Community Campus now offers Hidden Scar surgery technique
Hidden Scar Lumpectomy procedures use a single, discreet incision to preserve the majority of the breast, while removing the tumor and a small portion of healthy margin tissue. (Source: SUNY Upstate Medical)
Source: SUNY Upstate Medical - November 2, 2016 Category: Universities & Medical Training Source Type: news
Freezing technique is an effective alternative to lumpectomy for early stage breast cancer, study finds
A deep-freezing technique known as cryoablation is a viable alternative to traditional surgery in many early-stage breast cancers, researchers have found in a new clinical study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 27, 2016 Category: Science Source Type: news
AHN study clears less invasive treatment for breast cancer patients with pacemakers
A new study from Allegheny Health Network has found that early-stage breast cancer patients with pacemakers can be treated with lumpectomies and whole-breast radiotherapy, eliminating the need for some unnecessary mastectomies. The study, presented this week at the American Society for Radiation Oncology meeting in Boston, looked at 20 women with early stage breast cancer and cardiac pacing devices who had been advised to consider mastectomy. The women underwent lumpectomies, then radiation treatment… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 26, 2016 Category: Biotechnology Authors: Lydia Nuzum Source Type: news
New Study Shows Lumpectomy With Radiation Therapy to Treat Breast Cancer in a Community Setting Results in Higher Than Average Patient Survival Rates
Manhattan Beach, Cali. (August 25, 2016) – A recently published study in The Journal of Community and Supportive Oncology identifies two key research findings regarding breast cancer treatment options. First, breast conservation treatment (BCT), i.e. lumpectomy plus radiation therapy, delivered in a... (Source: McKesson News)
Source: McKesson News - August 25, 2016 Category: Information Technology Source Type: news
Dune Medical lands $3.4m EU grant
Dune Medical Devices said today it won a $3.4 million (EU €3 million) European Union Horizon 2020 research grant. The company said it is 1 of 65 companies selected to receive funding from the $91 billion (EU €80 billion) 7-year program aiming to “secure Europe’s global competitiveness.” “This 3 million euro grant will expedite bringing our soft tissue biopsy system to the market. It will provide radiologists and surgeons immediate graphic characterizations of tissue abnormalities along the tip of the biopsy needle, just before samples are taken. This real-time insight can help reduce ...
Source: Mass Device - August 23, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Diagnostics Oncology Dune Medical Devices Inc. Source Type: news
FDA adds new clearance for Cianna Medical ’ s Savi Scout breast cancer locator
Cianna Medical said today it won additional FDA 510(k) clearance for its Savi Scout radar localization breast cancer device, now cleared to be placed at the lumpectomy site up to 30 days prior to surgical removal. Aliso Viejo, Calif.-based Cianna’s Savi Scout is designed to produce audible and visual indicators surgeons can use to tag cancerous tissue during lumpectomy and biopsy procedures. The surgeon uses a hand piece that emits infrared light and electromagnetic waves to locate a reflector placed in target tissue as long as a week before surgery. After reaching the surgical bulls-eye, the surgeon takes out the ta...
Source: Mass Device - August 17, 2016 Category: Medical Equipment Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Oncology Regulatory/Compliance Cianna Medical Source Type: news
Why More Mastectomies?
I understand that more women with newly diagnosed breast cancer are choosing mastectomies, even double mastectomies, over lumpectomy. I've also heard that mastectomy is now an outpatient procedure, which seems outrageous. Can you tell me why this is happening? (Source: Dr. Weil Q and A)
Source: Dr. Weil Q and A - July 12, 2016 Category: Consumer Health News Source Type: news
Ipsilateral arm BP measurements after breast cancer?
A 47-year-old woman with a history of right-sided breast cancer – status after lumpectomy, lymph node dissection, and radiation – comes in to clinic for evaluation. She asks the MA to take... (Source: Family Practice News)
Source: Family Practice News - July 8, 2016 Category: Primary Care Source Type: news
MassDevice.com +5 | The top 5 medtech stories for June 24, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters. 5. InVivo Therapeutics touts case study in 1st spine scaffold implant InVivo Therapeutics this week touted a case study of the 1st implantation of its spinal scaffold, a bioresorbable device designed to help treat traumatic spinal...
Source: Mass Device - June 24, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news
U.K. launches study of Dune Medical’s MarginProbe breast cancer device
Dune Medical Devices said this week that the U.K.’s National Health Service is launching a study of its MarginProbe device, which is designed to spot cancerous cells on the margins of breast tumors. Paoli, Pa.-based Dune said the NHS’s National Institute of Health Research arm is funding a study to see whether MarginProbe reduces the need for further re-excision procedures after lumpectomy procedures. The 460-patient study, led by Dr. Nigel Bundrud of the University Hospital of Southern Manchester, is a randomized, prospective, double arm trial. It’s designed to&nbs...
Source: Mass Device - June 24, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Clinical Trials Oncology Women's Health Dune Medical Devices Inc. Source Type: news
Has breast MRI been performed upside down?
A new phase 1 clinical trial evaluated the differences between pre-operative prone and supine MRI exams in 12 women undergoing lumpectomy for breast cancer. Researchers demonstrated that considerable deformity of the breast and tumor position occurs when patients are imaged in the prone position. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 22, 2016 Category: Science Source Type: news
Has breast MRI been performed upside down?
(Brigham and Women's Hospital) A new phase 1 clinical trial from Brigham and Women's Hospital published in Radiology on June 22, 2016, evaluated the differences between pre-operative prone and supine MRI exams in 12 women undergoing lumpectomy for breast cancer. Researchers demonstrated that considerable deformity of the breast and tumor position occurs when patients are imaged in the prone position. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 22, 2016 Category: Cancer & Oncology Source Type: news
More Than Half A Million People Have Watched This Pregnancy Announcement
A brother's instant reaction to his sister's pregnancy announcement is a sweet reminder of how close siblings can be. On Wednesday, Facebook page Love What Matters shared an old video of Lindsay MacPhee-Currie's pregnancy announcement. In the video, which was filmed in August 2014, she offers her older brother, Callum MacPhee, a bottle of wine at her home in Nova Scotia and jokes that she originally got it for herself, but that she can't "drink for the next nine months." In tears, her brother immediately hugs her. The announcement came as a shock to MacPhee-Currie's family, since doctors told her that her ch...
Source: Healthy Living - The Huffington Post - June 17, 2016 Category: Consumer Health News Source Type: news
Study backs laser prostate ablation with Medtronic’s Artemis
Laser ablation may be a feasible and safe treatment option for men with intermediate risk prostate cancer, according to a new study published in the Journal of Urology. The treatment operates using magnetic resonance imaging to guide a laser fiber into a cancerous tumor in the prostate to destroy the tissue with extreme heat. The study of the technique, funded by Medtronic (NYSE:MDT) and undertaken at UCLA, reported no serious adverse effects or changes in urinary or sexual function at 6-months post procedure. “Our feeling was that if you can see prostate cancer using the fusion MRI and can put a needle in the s...
Source: Mass Device - June 10, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Catheters Clinical Trials Oncology Medtronic Source Type: news